Carregant...
Private Payer Coverage Policies for ApoE-e4 Genetic Testing
PURPOSE: ApoE-e4 has a well-established connection to late-onset Alzheimer’s disease (AD) and is available clinically. Yet, there have been no analyses of payer coverage policies for ApoE. Our objective is to analyze private payer coverage policies for ApoE genetic testing, examine the rationales, a...
Guardat en:
| Publicat a: | Genet Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035237/ https://ncbi.nlm.nih.gov/pubmed/33420342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-020-01042-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|